News

Scientists uncover a genetic "shield" that lowers the risk of colorectal cancer

m6A RNA modification in colorectal cancer: Regulatory roles, oncogenic signalling and metabolic pathways

European Commission approves enfortumab vedotin in combination with pembrolizumab as the first and only approved perioperative treatment option for cisplatin-ineligible patients with resectable muscle-invasive bladder cancer

European Commission approves encorafenib in combination with cetuximab and FOLFOX for the first-line treatment of adult patients with BRAF V600E-mutant metastatic colorectal cancer

Cervical cancer: NICE recommends cemiplimab immunotherapy for advanced cervical cancer

Pancreatic cancer discovery advances toward first-of-its-kind clinical trial

New AI-powered platform helps researchers find promising cancer therapies faster

A quantum mechanics approach to artificial intelligence can improve cancer outcomes

Foundational research points to new therapeutic strategies for an emerging cancer drug

New research shows how AI may help avoid unnecessary chemotherapy for breast cancer patients

Colon cancer cells may change identity to metastasise

Study finds prostate cancer screening discussions are rare – but make a big difference